Health Care REIT (NYSE: HCN) had its price target lifted by Raymond James from $63.50 to $67.00 in a research note released on Wednesday morning. They currently have an outperform rating on the stock.
A number of other analysts have also recently weighed in on HCN. Analysts at Barclays Capital reiterated an overweight rating on shares of Health Care REIT in a research note to investors on Wednesday. They now have a $70.00 price target on the stock, down previously from $71.00. Separately, analysts at Stifel Nicolaus raised their price target on shares of Health Care REIT from $64.00 to $67.00 in a research note to investors on Tuesday. They now have a buy rating on the stock.
Five research analysts have rated the stock with a buy rating, one has issued an overweight rating, ten have assigned a hold rating, and one has issued a sell rating to the company. Health Care REIT has an average rating of overweight and a consensus target price of $63.08.
Health Care REIT opened at 64.14 on Wednesday. Health Care REIT has a 52-week low of $52.40 and a 52-week high of $64.87. The stock’s 50-day moving average is currently $62.78. The company has a market cap of $16.631 billion and a price-to-earnings ratio of 64.85.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.